Carregant...
Lung cancer screening: who pays? who receives?—the Chinese perspective
The National Lung Screening Trial (NLST) revealed that low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20.0%. In China, LDCT is very cheap and easy to access. As a result, LDCT screening is not limited to “high-risk” population defined by the NLST trial. The results of...
Guardat en:
| Publicat a: | Transl Lung Cancer Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182701/ https://ncbi.nlm.nih.gov/pubmed/34164286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.16 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|